Chonluten
A synthetic tripeptide bioregulator (Glu-Asp-Gly) from the Khavinson system, studied for respiratory and bronchial mucosal health, anti-inflammatory gene regulation, and stress protection in lung tissue.
What is Chonluten?
Chonluten is a synthetic tripeptide consisting of glutamic acid, aspartic acid, and glycine (Glu-Asp-Gly), developed as part of Vladimir Khavinson's bioregulator peptide system at the St. Petersburg Institute of Bioregulation and Gerontology. It is classified as a Cytogen — a lab-synthesized short peptide designed to mirror the regulatory effects of peptides naturally found in bronchial and lung tissue. Its principal biological target is the respiratory system, specifically the bronchial mucosa and lung epithelium. It is often discussed alongside Bronchogen (AEDL), which targets deeper lung tissue and cell differentiation, while Chonluten is more associated with stress-protective and anti-inflammatory gene regulation in respiratory epithelium.
Why People Talk About It
Respiratory and bronchial mucosal health
PreliminaryAnti-inflammatory gene regulation in lung tissue
PreliminaryAdjunct support for chronic bronchitis and COPD
PreliminaryStress protection under low-oxygen conditions
LimitedAge-related respiratory decline
LimitedHow It Works
Chonluten is a tiny three-amino-acid peptide proposed to enter lung and bronchial cells, where it helps regulate genes involved in stress defense and inflammation. It may help the respiratory system manage oxidative stress and inflammatory responses by boosting protective gene programs — particularly those encoding antioxidant enzymes and heat-shock proteins.
Common Questions
Safety Information
Common Side Effects
Cautions
- • Not FDA-approved
- • Clinical data is limited and primarily from Russian research
- • No formal toxicology or pharmacokinetic studies meeting Western regulatory standards
- • No drug interaction studies have been conducted
- • Quality and purity vary by source
What We Don't Know
Western clinical trial data is absent. No dose-escalation studies, formal toxicology, or independent pharmacokinetic data exist. The claimed mechanism of direct DNA interaction by a tripeptide remains debated in the broader scientific community. Long-term safety has not been evaluated in controlled studies.
Published Research
6 studiesTransport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers
Molecular modeling shows EDG (Chonluten) has high binding affinity to LAT1 transporter, supporting cellular uptake.
Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
Demonstrated that Chonluten (EDG) inhibits TNF production in LPS-stimulated monocytes and acts as a natural inducer of TNF tolerance.
Peptide Regulation of Gene Expression: A Systematic Review
Systematic review of short peptide gene regulation including respiratory peptides AEDL and EDG.
Peptides: Prospects for Use in the Treatment of COVID-19
Reviews EDG tripeptide effectiveness for bronchopulmonary pathology and its stress-protective gene regulation (c-Fos, HSP70, SOD, COX-2, TNF-alpha).
Short Peptides Regulate Gene Expression
Molecular docking study of short peptide-DNA interactions including respiratory-related sequences.
Peptide regulation of gene expression and protein synthesis in bronchial epithelium
Demonstrates AEDL tetrapeptide regulation of bronchial epithelial genes; establishes framework for Khavinson respiratory peptide research.
Related Peptides
Epithalon
PreliminaryA synthetic tetrapeptide studied for its potential to activate telomerase and influence cellular aging.
Pinealon
PreliminaryBeginnerA short tripeptide studied for neuroprotective and cognitive-enhancing properties, part of the Khavinson peptide bioregulator family.
Cortagen
PreliminaryA synthetic peptide bioregulator targeting brain cortex function, studied for cognitive enhancement and neuroprotection in aging.
Cartalax
PreliminaryA synthetic tripeptide bioregulator (Ala-Glu-Asp) from the Khavinson system, studied for cartilage protection, joint health, and musculoskeletal aging.
Thymalin
ModerateA thymic peptide complex studied for immune system restoration, particularly in aging populations and immunocompromised states.
Vesugen
PreliminaryA synthetic tripeptide bioregulator (Lys-Glu-Asp) from the Khavinson system, studied for vascular protection, endothelial function, and age-related cardiovascular decline.
Quick Facts
- Class
- Bioregulator Peptide
- Evidence
- Preliminary
- Safety
- Limited Data
- Updated
- Apr 2026
- Citations
- 6PubMed
Also known as
Tags
Related Goals
Evidence Score
Clinical Trials
View Clinical TrialsLinks to ClinicalTrials.gov for reference. Listing does not imply endorsement.